[Pain management in sickle cell disease]

Area of Science:

• Hematology
• Pain Medicine
• Pharmacology

Background:

• Sickle cell disease (SCD) presents with diverse complications.
• Acute painful crises are a hallmark of SCD.
• Chronic pain affects many SCD patients, diminishing quality of life.

Purpose of the Study:

• To outline current pain management strategies for sickle cell disease.
• To provide guidance on treating acute painful crises and chronic pain in SCD.
• To address neuropathic pain considerations in SCD management.

Main Methods:

• Review of established pain management guidelines, including the World Health Organization (WHO) analgesic ladder.
• Discussion of pharmacological approaches for acute and chronic pain in SCD.
• Consideration of specific treatments for neuropathic pain.

Main Results:

• Acute painful crises in SCD can be managed using the WHO analgesic ladder.
• Chronic pain in SCD may be treated with long-acting and short-acting opioids.
• Neuropathic pain in SCD patients may benefit from anticonvulsants, antidepressants, or ketamine.

Conclusions:

• Adequate pain management is critical for improving the quality of life in sickle cell disease patients.
• A stepwise approach is recommended for managing SCD-related pain.
• Tailored pharmacological interventions are necessary for different pain types in SCD.